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Hormonal factors secreted by embryos and reproductive tracts are important for successful development of preimplantation embryos. We
found expression of brain-derived neurotrophic factor (BDNF) and neurotrophin-4/5 (NT-4/5) transcripts at its highest levels in the blastocyst
stages. The transcripts for their receptor, TrkB, were detectable throughout the early embryonic stages with an increase after the early blastocyst
stage. Both BDNF and TrkB are expressed in trophectoderm cells, whereas ligand-binding studies indicated specific binding of BDNF to
trophectoderm cells. Furthermore, BDNF and NT-4/5 were produced in pregnant oviducts and uteri. Treatment with BDNF promoted the
development of two-cell-stage embryos into blastocysts showing increased proliferation and decreased apoptosis. The effects of BDNF were
blocked by the TrkB ectodomain or a Trk receptor inhibitor, K252a. Studies using specific inhibitors demonstrated the roles of the PI3K, but
not the ERK, pathway in mediating BDNF actions. Under high-density embryo cultures, treatment with the TrkB ectodomain or K252a alone
also inhibited embryonic development and survival, suggesting potential autocrine actions of BDNF produced by the embryo. In vivo
experiments further demonstrated that K252a treatment suppressed early embryo development by inhibiting blastocyst cell numbers, and
increasing blastocyst apoptosis. Our findings suggested that BDNF signaling plays important paracrine roles during blastocyst development by
promoting the development of preimplantation embryos.
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Accumulating evidence indicates that a number of growth
factors and cytokines act as paracrine and/or autocrine factors
during early embryo development and implantation (Brison
and Schultz, 1998; Dey et al., 2004; Hardy and Spanos,
2002). Insulin-like growth factor-I, epidermal growth factor,
and other hormonal factors secreted by the maternal
reproductive tract regulate the development of pre- and peri-
implantation embryos through specific receptors (Dey et al.,
2004; Hardy and Spanos, 2002; Kane et al., 1997). In⁎ Corresponding author. 1-1-1 Hondo, Akita-shi, Akita, 010-8543, Japan. Fax:
+81 18 884 6447.
E-mail address: kawamura@yf7.so-net.ne.jp (K. Kawamura).
0012-1606/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2007.08.026addition, developing early embryos produce growth factors
that act in an autocrine manner to regulate their own growth
and differentiation, or to serve as paracrine factors by
regulating endometrial receptivity for blastocyst implantation.
Brain-derived neurotrophic factor (BDNF) is a member of
the neurotrophin family of proteins known to activate the high
affinity tyrosine kinase B (TrkB) receptor together with the
pan-neurotrophin low-affinity co-receptor p75 (Barbacid,
1994). Although neurotrophins are widely expressed in the
central nervous system and are important for neuronal
survival and differentiation (Jones et al., 1994), they also
play important roles in nonneuronal tissues (Ip et al., 1993).
In the ovary, BDNF was found to be essential for the
development of early follicles (Dissen et al., 1995; Paredes et
al., 2004; Spears et al., 2003). Based on DNA microarray
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recently found major increases in the expression of BDNF by
granulosa and cumulus cells following the preovulatory
luteinizing hormone (LH) surge. Consistent with identification
of TrkB receptors in the oocyte (Seifer et al., 2006), we
demonstrated that BDNF acts on its receptor, TrkB, in the
oocyte to enhance first polar body exclusion and to increase
the competence of oocytes for development into early
embryos (Kawamura et al., 2005c).
Here, we show the expression of BDNF and TrkB in pre-
implantation embryos and pregnant oviducts and uteri of mice.
We demonstrate paracrine and potential autocrine roles of the
BDNF/TrkB signaling system in the development of pre-
implantation embryos using BDNF and Trk receptor blockers,
and involvement of PI3K in BDNF signaling.Materials and methods
Animals
To obtain preimplantation embryos, female B6D2F1 mice at 25 days of
age (CLEA Japan, Tokyo, Japan) were treated with a single i.p. injection of
7 IU of human menopausal gonadotropin (HMG; ASKA Pharmaceutical,
Tokyo, Japan) followed 48 h later with 10 IU of human chorionic
gonadotropin (hCG; ASKA Pharmaceutical. Co., Ltd.) administrated i.p.
Immediately after hCG treatment, animals were allowed to mate and two-cell-
stage embryos were obtained by flushing the oviducts of mated mice at 46-
47 h after hCG injection for in vitro culture as described (Kawamura et al.,
2005a). Oviducts and uteri were obtained from immature untreated mice,
mice treated with HMG (7 IU), mice treated HMG followed 12 h later by
hCG treatment, and from animals at 4 days after mating. Pregnant oviducts
were also obtained daily from 1 to 3 days after mating. The care and use of
animals was approved by the Animal Research Committee, Akita University
School of Medicine.
Isolation of inner cell mass and trophectoderm cells
Inner cell mass and trophectoderm cells were isolated by immunosurgery as
described (Kawamura et al., 2005a). After zona removal and lysis using acid
Tyrode's solution (Sigma, St. Louis, MO), blastocysts were incubated
sequentially at 37 °C in rabbit anti-mouse serum (Sigma) diluted 1:10 in M2
medium (Sigma) for 10 min and then in guinea pig complement serum (Sigma)
diluted 1:3 in M2 medium with 10% FBS for 30 min. The lysed trophectoderm
cell fraction was subjected to RNA extraction. To remove remaining
trophectoderm cells, the inner cell mass was washed through small-bore glass
pipettes before RNA extraction. Total RNA was extracted using an RNeasy
Micro kit (QIAGEN, Tokyo, Japan) before RT-PCR to determine the spatial
expression of TrkB, BDNF, and NT-4/5 in the blastocysts. To confirm purity of
cell preparations, RT-PCR was performed to detect the inner cell mass marker
Oct-4 (Palmieri et al., 1994) and the trophectoderm marker urokinase
plasminogen activator (Robertson et al., 2001).
RT-PCR
For quantitative real-time RT-PCR, two-cell-stage embryos were obtained
by flushing the oviducts of mated mice at 46-47 h after hCG injection for in vitro
culture as described (Kawamura et al., 2005a). Embryos were allowed to
continue development to different stages and were then collected after culturing
in individual microdrops for 50-52 (four-cell), 59-60 (eight-cell), 70-72
(morula), 94-96 (early blastocyst), 119-120 (expanded blastocyst), and 142-
144 (hatched blastocyst) h after hCG injection. Quantitative real-time RT-PCR
of transcript levels in preimplantation embryos, oviducts and uteri was
performed using a SmartCycler (Takara, Tokyo, Japan) with primers and
hybridization probes for TrkB, BDNF, NT-4/5, and histone H2a as described(Kawamura et al., 2005c). Primers for TrkB corresponded to the catalytic kinase
domain of the receptor to avoid the amplification of truncated isoforms (Klein et
al., 1990). Data were normalized based on histone H2a transcript levels (Robert
et al., 2002).
For conventional RT-PCR to study cell types expressing specific genes,
primers for β-actin were used as described (Kawamura et al., 2003). PCR
reactions comprised 40 cycles of amplification with denaturation at 94 °C for
30 sec, annealing at 60 °C for 30 sec, and elongation at 72 °C for 30 sec. For
positive controls, mouse ovary cDNAwas amplified. For negative controls, no
mRNAwas included.
ELISA and immunohistochemistry
For ELISA, mouse uteri were homogenized in a buffer containing 137 mM
NaCl, 20 mM Tris-HCl, 1% Nonidet P40, 10% glycerol, and a protease
inhibitor cocktail (Roche Applied Science, Indianapolis, IN) before centrifu-
gation at 8000×g for 5 min at 4 °C. Quantification of BDNF in the
supernatant was performed as described (Kawamura et al., 2005c). Levels of
NT-4/5 were quantified using the DuoSet human NT-4 ELISA development
system (R and D Systems, Minneapolis, MN) The supernatant was diluted 1:4
in PBS for protein determination using the DC Protein Assay kit (Bio-Rad,
Hercules, CA).
Immunofluorescent detection of BDNF and NT-4/5 was performed using
mouse blastocysts as described (Kawamura et al., 2005a). Embryos were
fixed with 4% paraformaldehyde (Sigma) and then permeabilized in PBS with
0.2% Triton X-100 (Sigma) for 5 min at room temperature. After blocking,
embryos were incubated with either rabbit anti-BDNF or NT-4/5 polyclonal
antibodies (Chemicon, Temecula, CA) in 1% PBS-BSA with 0.05% Tween 20
(Sigma) at 1:500 dilution for 7 days at 4 °C. After three washes in Tris-
buffered saline with 0.1% Tween 20, embryos were incubated with Cy3
conjugated goat anti-rabbit IgG secondary antibodies (Zymed Laboratories,
San Francisco, CA) in 1% PBS-BSA with 0.05% Tween 20 at 1:1,000
dilution for 1 h at room temperature followed by three additional washes.
Counterstaining was performed for 30 min in 1 μg/ml of Hoechst 33342 dye
(Invitrogen, Carlsbad, CA). After five washes in PBS, embryos were analyzed
under a confocal laser scanning microscope (LSM 510, Carl Zeiss,
Oberkochen, Germany). For negative controls, the primary antibody was
replaced by nonimmune rabbit IgG (Dako, Carpinteria, CA).
To localize BDNF and NT-4/5, oviducts and uteri were obtained from
pregnant mice at four days after mating and fixed with Bouin's solution for
1 h at room temperature before transfer to 70% ethanol. Tissues were
embedded in paraffin and sectioned at 3-μm intervals. After deparaffinization
and dehydration, endogenous peroxidase activities were quenched with 3%
hydrogen peroxidase for 10 min. After incubation in the TNB blocking buffer
(TSA Biotin System; Perkin-Elmer, Boston, MA) for 30 min, slides were
incubated with either rabbit anti-BDNF or NT-4/5 polyclonal antibodies at
1:100 or 1:300 dilution for 48 or 166 h at 4 °C, respectively. After three
washes in the TNT buffer (0.1 M Tris-HCl, pH 7.5, 0.15 M NaCl, and 0.05%
Tween 20), slides were incubated with biotinylated anti-rabbit secondary
antibodies (Zymed Laboratories) for 1 h at room temperature. After three
washes, BDNF or NT-4/5 signals were amplified using the TSA Biotin
System. Bound antibodies were visualized using a Histostain SP kit (Zymed
Laboratories). For negative controls, the primary antibody was replaced by
nonimmune rabbit IgG.
Binding of fluorescent BDNF to preimplantation embryos
For binding studies, recombinant human BDNF (Peprotech, Rocky Hill,
NJ) was labeled with fluorescein isothiocyanate (FITC) using EZ-label FITC
protein labeling kit (Pierce Biotechnology, Rockford, IL). Two-cell-stage
embryos were cultured in modified M16 medium (MR-010-D; Chemicon)
without serum. When embryos reached the expanded blastocyst stage, medium
was replaced with the medium containing BDNF conjugated to FITC (FITC-
BDNF) and incubated for 30 min at 37 °C in air with 5% CO2. After three
washes, embryos were fixed with 4% paraformaldehyde in PBS for 15 min. To
determine background fluorescence, embryos were incubated with the medium
alone. Nonspecific binding of FITC-BDNF (30 ng/ml) was estimated by
coincubation with a 1,000-fold excess of unlabeled recombinant human
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embryos were visualized using a confocal laser scanning microscope (LSM
510, Carl Zeiss). Optical sections with intervals of 1 μm were taken with 63X/
1.4 Plan Apochromat objective and the fluorescent images were obtained as 8-
bit images of TIF format files. Using images without counterstaining, total
numbers of fluorescent pixels for individual embryos were calculated using
SigmaScan Pro 5.0 (SPSS Japan, Tokyo, Japan) to reflect the number of
binding sites for FITC-BDNF as described previously (Kawamura et al.,
2003).
Embryo cultures and apoptosis detection
Two-cell-stage embryos were obtained and groups of 10-12 embryos were
placed in 50 μl drops of modified M16 medium with or without BDNF and
covered by mineral oil. Embryos were cultured for 96 h up to the hatched
blastocyst stage with fresh medium replacement every 24 h. Some embryos
were cultured with BDNF (10 ng/ml) with or without the TrkB ectodomain (1
or 10 μg/ml; R and D Systems, Minneapolis, MN), a pan-specific Trk
receptor inhibitor, K252a (100 nM; Calbiochem, La Jolla, CA) (Tapley et al.,
1992), or plasma membrane nonpermeable K252b (100 nM) (Ross et al.,
1995). To examine endogenous effects of TrkB ligands on early embryonic
development and survival, groups of 40-43 embryos were cultured in 10 μl
drops of modified M16 medium with or without TrkB ectodomain (10 μg/ml),
K252a (100 nM) or K252b (100 nM). To analyze the involvement of PI3K
and ERK pathways in the BDNF induction of early embryonic development
and survival, groups of 10-12 two-cell-stage embryos were cultured with
BDNF (10 ng/ml) with or without a PI3K inhibitor, LY294002 (1-10 μM;
Sigma) or its inactive analog, LY303511 (10 μM; Calbiochem). Some
embryos were cultured with BDNF with or without a MEK1/2 inhibitor,
U0126 (5-50 μM; Calbiochem) or its inactive analog, U0124 (50 μM;
Calbiochem). Embryonic development was monitored after 24, 72, and 96 h
of culture to determine the proportion of embryos at morula, expanded
blastocyst, and hatched blastocyst stages, respectively. At the end of culture,
some embryos were subjected to the terminal deoxynucleotidyl transferase
mediated dUTP nick end labeling (TUNEL) assay to detect apoptosis as
described (Kawamura et al., 2005b).
Differential labeling of inner cell mass and trophectoderm cells
To examine the preferential effect of BDNF on specific cell lineages in
blastocysts, the numbers of inner cell mass and trophectoderm cells in
blastocysts were counted by the differential labeling technique using two
polynucleotide-specific fluorochromes (Kawamura et al., 2003). After staining,
the blastocysts were mounted on a glass slide, and the number of total, inner cell
mass and trophectoderm cells in each blastocyst was counted under an
epifluorescence microscope (Olympus Corp., Tokyo, Japan).
In vivo analysis
To examine the roles of endogenous TrkB ligands during early embryonic
development in vivo, female B6D2F1 mice at 25 days of age were treated with
HMG (7 IU) followed 48 h later with 10 IU hCG. Immediately after hCG
injection, animals were allowed to mate with fertile males. Because in vitro
studies indicated minimal effects of BDNF on early embryos up to the morula
stage, K252a was administrated three times (i.p.; 10 μg×3) at 79, 83, and 87 h
after hCG injection thus corresponding to the development of morula to the
blastocyst stage in vivo (Kawamura et al., 2005c). For negative controls, K252b
or vehicle alone was used. At 90-92 h after hCG injection, expanded blastocysts
were obtained from uterine horns. After evaluation of the proportion of embryos
that developed to the expanded blastocyst stage, embryos were subjected to the
TUNEL assay.
Statistical analysis
Mann-Whitney U test was performed to compare the number of total, inner
cell mass and trophectoderm cells in blastocysts. One-way ANOVA, followed
by Fisher's protected least significant difference test, was used to evaluate otherdifferences. Results are presented as mean±s.e.m. of at least three separate
experiments.
Results
Temporal and spatial expression of neurotrophins and Trk
receptors in preimplantation embryos
Quantitative real-time RT-PCR was performed to examine
temporal expression of neurotrophins and the TrkB receptor in
preimplantation embryos. Levels of both BDNF and NT-4/5
mRNAs were low from the two-cell stage up to the four-cell
stage but increased at the eight-cell stage and reaching its highest
levels in the expanded and hatched blastocyst stages (Fig. 1A).
Likewise, TrkB mRNA levels were low from the two-cell stage
up to the morula stage and then increased at the early blastocyst
stage before reaching the highest levels in the hatched blastocyst
stage (Fig. 1A).
Inner cell mass and trophectoderm cells were isolated for
RT-PCR analyses to determine the cell types expressing BDNF,
NT-4/5, and TrkB in blastocysts. All three transcripts were
detected in trophectoderm cells and not in inner cell mass
cells (Fig. 1B). The expression of BDNF and NT-4/5 in tro-
phectoderm cells was further confirmed using immunofluor-
escent staining (Fig. 1C).
Binding of fluorescent BDNF to blastocysts
To confirm the expression of functional TrkB receptors in
blastocysts, ligand-binding studies were performed using
fluorescent-labeled FITC-BDNF. The clustered fluorescent
signals were detected in trophectoderm cells but not in cells
of the inner cell mass (Fig. 2). The ratios of fluorescent pixels
per embryo were saturated at 10 ng/ml of FITC-BDNF by
embryos treated with 30 ng/ml of FITC-BDNF showing a
similar level of fluorescent signals (Table 1).
Expression of BDNF, NT-4/5, and TrkB in preimplantation
oviducts and uteri
We also examined the expression of TrkB and its ligands in
oviducts and uteri during the preimplantation period. In oviducts,
quantitative real-time RT-PCR analyses indicated that BDNF
mRNA levels were high in immature mice at 25 days of age
(Fig. 3A, 0 h), and decreased after HMG treatment, whereas
BDNF mRNA levels increased at 12 h after treatment with hCG
to induce ovulation (Fig. 3A). In contrast, NT-4/5 mRNA levels
remained low following gonadotropin treatments, and increased
from days 2 of pregnancy (Fig. 3A). However, TrkB mRNAwas
low in both non-pregnant and pregnant oviducts (Fig. 3A).
In the uterus, levels of BDNF, NT-4/5, and TrkBmRNAs were
high in immature mice at 25 days of age (Fig. 4A, 0 h), decreased
after HMG treatment, and maintained at low levels until 12 h after
hCG treatment (Fig. 4A). However, BDNF and NT-4/5 mRNA
levels were increased at days 4 of pregnancy (Fig. 4A). Similar
changes of uterine BDNF and NT-4/5 proteins were detected
based on ELISA (Fig. 4B). Although the BDNF mRNA levels
Fig. 1. Temporal and spatial expression of transcripts for BDNF, NT-4/5, and TrkB in mouse preimplantation embryos. (A) Transcript levels for different genes in
developing preimplantation embryos were determined using real-time RT-PCR. Levels of all mRNAs were normalized based on those for histone H2a in the same
sample (mean±SEM, n=3). *, Pb0.01 vs. 2C. 2C: 2-cell; 4C: 4-cell; 8C: 8-cell; M: morula; B: early blastocyst; EB: expanded blastocyst; HB: hatched blastocyst. (B)
Spatial expression of BDNF, NT-4/5, and TrkB in blastocysts. Oct_4 and urokinase plasminogen activator (uPA) transcripts were used as markers for inner cell mass
(ICM) and trophectoderm (TE), respectively. Levels of β–action served as loading controls. BL: whole blastocyst; NC: negative control. (C) Immunohistochemical
detection of BDNF and NT-4/5 proteins in blastocysts. Specific BDNF and NT-4/5 signals are localized in TE cells (arrowhead), but not ICM cells (arrow). (Lower)
Negative controls. Embryonic nuclei were stained in blue with Hoechst 33342. (Scale bars, 20 μm).
150 K. Kawamura et al. / Developmental Biology 311 (2007) 147–158were comparable to those of NT-4/5, uteri expressed higher levels
of BDNF than NT-4/5 proteins (Figs. 4A and B).
Immunohistochemical analyses further indicated that both
BDNF and NT-4/5 were expressed in the oviductal epithelial
cells and the endometrial epithelial cells but not in stromal
cells (Figs. 3B and 4C, a and b, BDNF and NT-4/5 staining; c
and d, negative controls). BDNF staining was stronger than
that of NT-4/5 in both oviducts and uteri (Figs. 3B and 4C).
Effects of BDNF treatment on the development of
preimplantation embryos in vitro
The expression of BDNF and TrkB in preimplantation
embryos, oviducts and uteri suggests the BDNF/TrkB signalingsystem could play a role during early embryonic development.
We then tested the effect of BDNF treatment on cultured
embryos. Although BDNF treatment did not affect the
development of two-cell-stage embryos to the morula stage
(data not shown), BDNF treatment promoted the development
of embryos to the expanded and hatched blastocyst stages
evaluated after 72 and 96 h of culture, respectively, when
embryos were cultured at a low density (Fig. 5A). At 96 h,
BDNF treatment doubled the proportion of blastocysts reaching
the hatched stage. The specificity of the effects of BDNF on
preimplantation embryos was examined by using the soluble
ectodomain of TrkB or a Trk receptor inhibitor, K252a. The
ability of BDNF to promote the development of two-cell-stage
embryos to the hatched blastocyst stage was blocked by
Fig. 2. Binding of BDNF to blastocysts. Blastocysts were treated with 1–30 ng/
ml of FITC-BDNF. For nonspecific binding, blastocysts were treated with
medium alone (a) or 30 ng/ml of FITC-BDNF and a 1,000-fold excess of
unlabeled BDNF (b). The clustered fluorescent signals of FITC-BDNF were
detected in TE cells (arrowhead), but not ICM cells (arrow). Embryonic nuclei
were stained in blue with Hoechst 33342. (Scale bars, 20 μm).
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with the membrane nonpermeable K252b (Fig. 5B).
Because treatment of embryos cultured at a low density
with the TrkB ectodomain or K252a alone without BDNF hasTable 1
Ratio of flurescent pixels obtained from confocal microscopic eight-bit images of m
BDNF Number of fluorescent
pixels (A)
1 ng/ml 7471±990
3 ng/ml 11151±1302
10 ng/ml 30927±2639
30 ng/ml 36731±2382
A total of five embryos were used in each concentration.no effect on the development of two-cell-stage embryos to the
hatched blastocyst stage (Fig. 5B), the concentration of
endogenously-produced BDNF in the culture medium might
not be high enough to exert autocrine effects on embryos. To
examine the effect of endogenous TrkB ligands on embryo
development, embryos were cultured at higher density to
increase the concentration of endogenous TrkB ligands in the
culture medium before treatment with the TrkB ectodomain or
K252a alone (Fig. 5C). The proportions of embryos at the
hatched blastocyst stage in the control group were increased
following culture at a high density, whereas the increased
development of embryos was inhibited by treatment with
the TrkB ectodomain or K252a, but not the inactive K252b
(Fig. 5C).
Effects of BDNF treatment on apoptosis of cultured blastocysts
To determine if BDNF acts as a survival factor, we
evaluated apoptosis in embryos treated with BDNF. Because
hatched blastocysts are difficult to retrieve due to extreme
viscosity, expanded blastocysts were used for TUNEL staining
(Fig. 6A). Cell counting indicated that BDNF treatment
increased the total number of cells in blastocysts cultured at
a low density, and the increase of cell number was pre-
ferentially observed in trophectoderm cells (Figs. 6B and C).
We also detected decreases in the proportion of TUNEL-
positive nuclei (Figs. 6A and D), thus suggesting the BDNF
suppression of apoptosis. Furthermore, the effects of BDNF on
cell number and apoptosis of blastocysts cultured at a low
density were blocked by cotreatment with the TrkB ectodo-
main or K252a, but not with K252b (Figs. 6B and D). Similar
to studies on embryonic development, treatment with the TrkB
ectodomain or with K252a, but not K252b, decreased cell
numbers and increased numbers of TUNEL-positive nuclei in
the blastocysts cultured at a high density without BDNF (Figs.
6E and F).
Involvement of the PI3K, but not ERK, pathway in the BDNF
promotion of preimplantation embryo development and
survival
We further analyzed the roles of PI3K and ERK signaling
pathways as downstream mediators of the BDNF/TrkB-
induced embryo development and survival. The ability of
BDNF to promote the development of two-cell-stage embryos
to the hatched blastocyst stage at a low density was suppressedouse blastocyst
Number of pixels in
whole embryo's area (B)
Ratio of pixels
per embryo (A/B)
55293±1824 0.1369±0.0207
54514±1942 0.2051±0.0252
5658±2519 0.5593±0.0514
56661±2130 0.6467±0.0262
Fig. 3. Expression of BDNF and NT-4/5 in mouse oviducts. (A) Quantification of BDNF, NT-4/5, and TrkB transcripts using real-time RT-PCR. Levels of BDNF, NT-
4/5, and TrkBmRNAs were obtained at different times after HMG and hCG treatment and normalized using transcript levels of histone H2a in the same sample (mean±
SEM, n=3). Some samples were obtained from animals at days 1 through 4 of pregnancy. For each stage, three samples prepared from individual animals were used.
*,Pb0.01 vs. oviducts from animals treated with HMG for 48 h. (B) Localization of BDNF andNT-4/5 proteins in oviducts. Immunohistochemical analyses showed the
expression of BDNF and NT-4/5 proteins in pregnant oviducts at 4 days after mating. a and b: BDNF or NT-4/5 staining. c and d: negative controls. Specific BDNF and
NT-4/5 staining was localized to epithelial cells, but not stromal, cells. (Scale bars: 50 μm).
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its inactive analog, LY303511 in a dose-dependent manner
(Fig. 7A). In contrast, cotreatment with different doses of the
MEK1/2 inhibitor, U0126, had no effect on the BDNF-
induced embryo development (Fig. 7A). Furthermore, treat-
ment with LY294002 inhibited the BDNF stimulation of cell
numbers (Fig. 7B) and suppression of the percentage of
TUNEL-positive nuclei (Fig. 7C) in blastocysts cultured at a
low density. In contrast, U0126 did not alter BDNF actions on
cell number and apoptosis (Figs. 7B and C).In vivo effects of a Trk receptor inhibitor on the development of
preimplantation embryos
By using the Trk receptor inhibitor, K252a, we examined the
role of endogenous TrkB ligands during early embryonic
development in vivo. Treatment with K252a inhibited the number
of embryos reaching the expanded blastocyst stage (Fig. 8A)
without affecting the total number of embryos found (vehicle,
55.2±9.3; K252a, 56.3±3.7; K252b, 58.5±7.9). Assessment of
cell numbers indicated that treatment with K252a also decreased
Fig. 4. Expression of BDNF and NT-4/5 in mouse uteri. Quantification of BDNF, NT-4/5, and TrkB levels using real-time RT-PCR (A) and ELISA (B). Levels of
BDNF, NT-4/5, and TrkB mRNAs were obtained at different times after HMG and hCG treatment and normalized using transcript levels of histone H2a in the same
sample (mean±SEM, n=3). Some samples were obtained from animals at days 4 of pregnancy. For each stage, three samples prepared from individual animals were
used. *, Pb0.01 vs. uteri from animals treated with HMG for 48 h. (C) Localization of BDNF and NT-4/5 proteins in uteri. Immunohistochemical detection of BDNF
and NT-4/5 proteins in pregnant uteri at 4 days after mating. a and b: BDNF or NT-4/5 staining. c and d: negative controls. Specific BDNF and NT-4/5 staining was
localized to endometrial epithelial, but not stromal, cells. (Scale bars: a and c, 100 μm; b and d, 10 μm).
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percentage of TUNEL-positive nuclei increased after K252a
treatment (Fig. 8C). In contrast, treatment with K252b was
ineffective for all three parameters tested.
Discussion
The present study demonstrates the ability of BDNF to
promote early embryonic development and to suppress embryoapoptosis, suggesting the inclusion of this factor could be
important for in vitro embryo cultures and embryonic stem cell
derivation. Because our previous (Kawamura et al., 2005c) and
unpublished data indicate the absence or very low expression of
both BDNF and NT-4/5 mRNA in oocytes, transcription of
BDNF and NT-4/5 may be triggered by zygotic genome
activation. The high expression of TrkB in trophectoderm cells
of expanded and hatched blastocysts is likely responsible for the
observed ability of BDNF to promote early embryonic devel-
Fig. 5. BDNF promotion of the development of cultured preimplantation
embryos. (A) Effects of BDNF treatment on early embryonic development.
Two-cell-stage embryos (10–12 embryos/50 μl culture drop) were cultured
without (control, C) or with BDNF for 72 and 96 h to evaluate the proportion of
embryos at expanded and hatched blastocyst stages, respectively. (Mean±SEM,
n≥6, 62–75 embryos per group.) (B) Antagonistic effects of the TrkB
ectodomain (TrkB EC) and the Trk receptor inhibitor, K252a on the BDNF
stimulation of embryo development. Two-cell-stage embryos were cultured for
96 h with BDNF (10 ng/ml) with or without TrkB ectodomain (10 μg/ml),
K252a (100 nM), or K252b (100 nM). (Mean±SEM, n ≥5, 50–72 embryos
per group.) (C) Effects of blockade of endogenous TrkB ligands on embryonic
development. Two-cell stage embryos in groups at a high density (40–43
embryos/10 μl culture drop) were cultured for 96 h in modified M16 medium
alone (C), TrkB ectodomain (10 μg/ml), K252a (100 nM), or K252b (100 nM).
(Mean±SEM, n=5, 203–210 embryos per group.) *, Pb0.01 vs. control
group.
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with the TrkB ectodomain and the Trk inhibitor, K252a
suppressed development and survival of early embryos cultured
at a high density, endogenous TrkB ligands (BDNF and NT-4/5)
produced by the embryos could play important roles duringearly embryonic development. Because BDNF and NT-4/5 are
also secreted by oviductal and uterine epithelial cells, the
observed in vivo actions of BDNF on blastocyst development
and survival could involve paracrine as well as autocrine actions
of BDNF and/or NT-4/5. Using specific inhibitors, we also
showed the contribution of the PI3K signaling pathway in the
BDNF promotion of early embryonic development.
Treatment with BDNF promoted the development of
cultured preimplantation embryos from the two-cell stage to
expanded and hatched blastocyst stages, and the observed
effects were blocked by the TrkB ectodomain or the Trk
receptor inhibitor, K252a. Although the ability of BDNF to
promote early embryonic development was not observed prior
to the blastocyst stage, BDNF may regulate cellular functions
or “condition” the early embryos in preparation for blastocyst
development. However, it cannot be ruled out the possibility
that the downstream pathways of the BDNF/TrkB signaling
are not operational before the blastocyst stage. The effect of
BDNF to promote blastocyst development is correlated with
its ability to inhibit apoptosis and increase total cell numbers
in blastocysts. The apoptosis-suppressing effect of BDNF is
consistent with earlier studies showing the survival actions of
BDNF on cells of the central nervous system (Han and
Holtzman, 2000; Hetman et al., 1999) and some peripheral
tissues (Botchkarev et al., 2004; Pyle et al., 2006; Raap et al.,
2005).
Both the BDNF promotion of blastocyst development and
the suppression of embryonic cell apoptosis were blocked by
cotreatment with K252a. Although K252a is a pan-specific
Trk receptor inhibitor, the observed inhibitory effect is likely
specific for the TrkB receptor because the other two
paralogous receptors, TrkA and TrkC, were not detectable
in mouse preimplantation embryos (data not shown). Because
the concentration of endogenous hormonal ligands in the
culture medium are higher when embryos are cultured at a
high density (Paria and Dey, 1990), potential autocrine roles
of TrkB ligands of embryonic origin during early embryonic
development was examined in embryos cultured at a high
density following treatment with the TrkB ectodomain or
K252a without exogenous BDNF. Because treatment with the
TrkB ectodomain or K252a inhibited embryo development
and survival under high-, but not low, -density cultures, our
findings suggest that the concentration of endogenous BDNF
could be increased under high-density cultures to allow
demonstration of the inhibitory effects of the TrkB ectodo-
main or K252a. However, this in vitro culture system is
artificial and may not entirely reflect exact in vivo conditions.
The important roles of the BDNF/TrkB signaling system in
pregnant mice in vivo are underscored by the suppressive
effect of the TrK receptor inhibitor, K252a, on blastocyst
development and survival when injected into mice during the
preimplantation period. Of importance, the related plasma
membrane nonpermeable K252b was ineffective. BDNF and
NT-4/5 may compensate for each other in vivo due to their
actions through the same receptor, TrkB. Thus, the impor-
tance of the TrkB ligands signaling system during develop-
ment of preimplantation embryos could only be investigated
Fig. 6. Treatment with BDNF suppresses apoptosis in cultured blastocysts. (A) Detection of apoptotic nuclei by TUNEL staining in blastocysts with or without
treatment with BDNF (10 ng/ml). Two-cell-stage embryos were cultured for 72 h before TUNEL analysis. red: counterstained nuclei, yellow: TUNEL_stained
nuclei. (Scale bars, 20 μm.) (B and D) Effects of BDNF treatment on cell number and apoptosis in blastocysts. Two-cell-stage embryos were cultured for 72 h
with or without BDNF (10 ng/ml) and the specificity of BDNF actions was evaluated by cotreatment with the TrkB ectodomain (TrkB EC) (10 μg/ml), K252a
(100 nM), or K252b (100 nM). (Mean±SEM, total n=20 embryos per group.) (C) Effects of BDNF treatment on the number of total, TE, and ICM cells in
blastocysts. Two-cell-stage embryos were cultured for 72 h with or without BDNF (10 ng/ml). (Mean±SEM, total n=20 embryos per group.) (E and F) Effects
of blockade of endogenous TrkB ligands on cell number and apoptosis in blastocysts. Two-cell stage embryos in groups at a high density were cultured for 72 h
in modified M16 medium alone (CH), TrkB ectodomain (10 μg/ml), K252a (100 nM), or K252b (100 nM). (Mean±SEM, total n=20 embryos per group.)
*, Pb0.01 vs. control group.
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However, no pregnant mice for either TrkB null or BDNF
and NT-4/5 double null animals are available because these
animals die shortly after birth (Klein et al., 1993; Liu et al.,
1995). Furthermore, studies on the role of TrkB ligands
during embryonic development in pups lacking both BDNF
and NT-4/5 are complicated due to compensation by oviductal
and uterine BDNF and/or NT-4/5 in heterozygous mutant
mothers. Congenic strain of TrkB null mice of the C57BL/6
line showed defects in embryonic development because only
less than 3% of TrkB null pups were delivered at the time of
birth (Spears et al., 2003) as compared with the expected ratio
of 25%. These findings are consistent with the present
findings of paracrine roles of the TrkB ligands during earlyembryonic development. Future studies on the stage of em-
bryonic arrest in congenic TrkB mutant mice could reveal the
exact roles of TrkB and its ligands during embryonic
development before and after implantation.
The observed exclusive expression of TrkB and its ligands
in trophectoderm cells of blastocysts are consistent with our
findings of a preferential effect of BDNF on the cell pro-
liferation of trophectoderm cells. The potential roles of TrkB
expressed in trophectoderm cells to mediate BDNF actions
are further underscored by the demonstration of the exclusive
binding of fluorescence-labeled BDNF to trophectoderm cells,
similar to the formation of receptor-ligand complexes found
for neuronal cells (Beaudet et al., 1998; Fabry et al., 2000).
Because trophectoderm cells of blastocysts differentiate
Fig. 7. Involvement of the PI3K pathway in the BDNF promotion of early embryonic development and survival. Effects of PI3K or MEK1/2 inhibitors on the BDNF
promotion of preimplantation embryo development (A), stimulation of cell numbers in blastocysts (B), and suppression apoptosis (C). Two-cell-stage embryos were
cultured without (control, C) or with BDNF (10 ng/ml) with or without the inhibitor of PI3K, LY294002 (LY2, an inhibitor of PI3K) or its inactive analog, LY303511
(LY3). Some embryos were treated with BDNF with or without U0126 (an inhibitor of MEK1/2), or its inactive analog, U0124. At 96 h after culture, the proportion of
embryos at hatched blastocyst stage was evaluated. (Mean±SEM, n=5, 52–53 embryos per group.) Total cell number and TUNEL-positive nuclei in the expanded
blastocysts were determined (Mean±SEM, total n=20 embryos per group) at 72 h after culture. *, Pb0.01 vs. BDNF group.
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blasts that mediate embryo implantation into the uterine wall,
our findings suggest a potential involvement of BDNF during
implantation.
Following binding of BDNF, TrkB induces a complex
signaling cascade, including PI3K and ERK pathways in
neurons to promote neuronal survival in neurons (Kaplan and
Miller, 2000; Yuan and Yankner, 2000). In preimplantation
embryos, we demonstrated that the BDNF-promoted embryo
development and survival is mediated thorough the PI3K, but
not the ERK pathway. Although the ERK pathway is present
in preimplantation embryos (Wang et al., 2004), recent study
showed that blockade of the JNK or p38 MAPK pathway, butnot of the ERK pathway, resulted in the inhibition of the
development of mouse preimplantation embryos (Maekawa et
al., 2005). Thus, the ERK pathway may not be less important
for the early embryonic development.
BDNF and NT-4/5, the two specific ligands for TrkB, are
expressed in the trophectoderm cells of blastocysts. They are
also detectable in the oviductal and uterine epitheliums based
on RT-PCR and immunoassays. Because preimplantation
embryos develop in the oviduct until early on day 4 of
pregnancy when they reach the late morula/blastocyst stage
and then migrate to the uterus, observed increases in levels
of TrkB ligands in the oviduct and uterus during the pre-
implantation period suggest their paracrine roles during early
Fig. 8. Roles of endogenous TrkB ligands during embryonic development in
vivo. Effects of K252a treatment in vivo on the development of preimplantation
embryos (A), cell numbers in blastocysts (B), and apoptosis (C). HMG-primed
immature mice were treated with hCG to induce ovulation before mating. Mice
were treated with or without K252a or K252b (10 μg/injection at 79, 83, and
87 h after hCG). At 90–92 h after hCG injection, the number of expanded
blastocysts was evaluated (n≥4 animals). Subsequently, total cell number and
TUNEL-positive nuclei in the blastocysts were determined (n=20 embryos).
*, Pb0.01 vs. vehicle group.
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and NT-4/5 in pregnant oviduct and uterus were comparable,
BDNF proteins were more abundant, suggesting oviductal and
uterine BDNF could act on TrkB expressed in blastocysts via
paracrine mechanisms. Because both TrkB and its ligands are
expressed in the oviduct and uterus, their autocrine/paracrine
roles in the oviduct and uterus cannot be ruled out.
Herein, we have demonstrated important roles of the BDNF/
TrkB signaling system in the development and survival of
preimplantation embryos based on in vitro and in vivo studies.
It is becoming clear that this ligand signaling system, originally
found to be essential for the development and differentiation of
the neuronal system, is also important for diverse female
reproductive processes including the development of early
ovarian follicles (Dissen et al., 1995; Paredes et al., 2004;
Spears et al., 2003), the nuclear and cytoplasmic maturation of
oocytes into preimplantation embryos (Kawamura et al.,
2005c), and early embryonic development. The present
demonstration of an augmenting role for the BDNF/TrkB
signaling pathway in early embryos underscores the importanceof diverse autocrine/paracrine systems for early embryonic
development. Understanding of these intercellular communica-
tion networks could lead to new approaches in the treatment of
infertility, and facilitate future formulation for the optimal
culture conditions for in vitro fertilization and embryonic stem
cell derivation.
Acknowledgments
We thank C. Spencer for editorial assistance. This work was
supported by a Grant-in-Aid for Scientific Research (K.K.;
Grant-In-Aid for Young Scientists B: 177911010 and
19791133, and T.T.; Grant-In-Aid for Scientific Research B:
18390444) and research funds from the Yamaguchi Endocrine
Research Association (K.K.), the Kanae Foundation for Life
and Socio-medical Science (K.K.), and the Kanzawa Medical
Research Foundation (K.K.).ReferencesBarbacid, M., 1994. The Trk family of neurotrophin receptors. J. Neurobiol. 25,
1386–1403.
Beaudet, A., Nouel, D., Stroh, T., Vandenbulcke, F., Dal-Farra, C., Vincent, J.P.,
1998. Fluorescent ligands for studying neuropeptide receptors by confocal
microscopy. Braz. J. Med. Biol. Res. 31, 1479–1489.
Botchkarev, V.A., Botchkareva, N.V., Peters, E.M., Paus, R., 2004. Epithelial
growth control by neurotrophins: leads and lessons from the hair follicle.
Prog. Brain Res. 146, 493–513.
Brison, D.R., Schultz, R.M., 1998. Increased incidence of apoptosis in
transforming growth factor alpha-deficient mouse blastocysts. Biol. Reprod.
59, 136–144.
Dey, S.K., Lim, H., Das, S.K., Reese, J., Paria, B.C., Daikoku, T.,
Wang, H., 2004. Molecular cues to implantation. Endocr. Rev. 25,
341–373.
Dissen, G.A., Hirshfield, A.N., Malamed, S., Ojeda, S.R., 1995. Expression of
neurotrophins and their receptors in the mammalian ovary is developmen-
tally regulated: changes at the time of folliculogenesis. Endocrinology 136,
4681–4692.
Fabry, M., Langer, M., Rothen-Rutishauser, B., Wunderli-Allenspach, H.,
Hocker, H., Beck-Sickinger, A.G., 2000. Monitoring of the internalization of
neuropeptide Yon neuroblastoma cell line SK-N-MC. Eur. J. Biochem. 267,
5631–5637.
Han, B.H., Holtzman, D.M., 2000. BDNF protects the neonatal brain from
hypoxic-ischemic injury in vivo via the ERK pathway. J. Neurosci. 20,
5775–5781.
Hardy, K., Spanos, S., 2002. Growth factor expression and function in the
human and mouse preimplantation embryo. J. Endocrinol. 172,
221–236.
Hetman, M., Kanning, K., Cavanaugh, J.E., Xia, Z., 1999. Neuroprotection by
brain-derived neurotrophic factor is mediated by extracellular signal-
regulated kinase and phosphatidylinositol 3-kinase. J. Biol. Chem. 274,
22569–22580.
Ip, N.Y., Stitt, T.N., Tapley, P., Klein, R., Glass, D.J., Fandl, J., Greene, L.A.,
Barbacid, M., Yancopoulos, G.D., 1993. Similarities and differences in the
way neurotrophins interact with the Trk receptors in neuronal and
nonneuronal cells. Neuron 10, 137–149.
Jones, K.R., Farinas, I., Backus, C., Reichardt, L.F., 1994. Targeted disruption of
the BDNF gene perturbs brain and sensory neuron development but not
motor neuron development. Cell 76, 989–999.
Kane, M.T., Morgan, P.M., Coonan, C., 1997. Peptide growth factors and
preimplantation development. Hum. Reprod. Update 3, 137–157.
Kaplan, D.R., Miller, F.D., 2000. Neurotrophin signal transduction in the
nervous system. Curr. Opin. Neurobiol. 10, 381–391.
158 K. Kawamura et al. / Developmental Biology 311 (2007) 147–158Kawamura, K., Sato, N., Fukuda, J., Kodama, H., Kumagai, J., Tanikawa, H.,
Nakamura, A., Honda, Y., Sato, T., Tanaka, T., 2003. Ghrelin inhibits the
development of mouse preimplantation embryos in vitro. Endocrinology
144, 2623–2633.
Kawamura, K., Fukuda, J., Kumagai, J., Shimizu, Y., Kodama, H., Nakamura,
A., Tanaka, T., 2005a. Gonadotropin-releasing hormone I analog acts as
an antiapoptotic factor in mouse blastocysts. Endocrinology 146,
4105–4116.
Kawamura, K., Fukuda, J., Shimizu, Y., Kodama, H., Tanaka, T., 2005b.
Survivin contributes to the anti-apoptotic activities of transforming growth
factor alpha in mouse blastocysts through phosphatidylinositol 3′-kinase
pathway. Biol. Reprod. 73, 1094–1101.
Kawamura, K., Kawamura, N., Mulders, S.M., Sollewijn Gelpke, M.D., Hsueh,
A.J., 2005c. Ovarian brain-derived neurotrophic factor (BDNF) promotes
the development of oocytes into preimplantation embryos. Proc. Natl. Acad.
Sci. U. S. A. 102, 9206–9211.
Klein, R., Conway, D., Parada, L.F., Barbacid, M., 1990. The trkB tyrosine
protein kinase gene codes for a second neurogenic receptor that lacks the
catalytic kinase domain. Cell 61, 647–656.
Klein, R., Smeyne, R.J., Wurst, W., Long, L.K., Auerbach, B.A., Joyner,
A.L., Barbacid, M., 1993. Targeted disruption of the trkB neurotrophin
receptor gene results in nervous system lesions and neonatal death. Cell 75,
113–122.
Liu, X., Ernfors, P., Wu, H., Jaenisch, R., 1995. Sensory but not motor neuron
deficits in mice lacking NT4 and BDNF. Nature 375, 238–241.
Maekawa, M., Yamamoto, T., Tanoue, T., Yuasa, Y., Chisaka, O., Nishida, E.,
2005. Requirement of the MAP kinase signaling pathways for mouse
preimplantation development. Development 132, 1773–1783.
Palmieri, S.L., Peter, W., Hess, H., Scholer, H.R., 1994. Oct-4 transcription
factor is differentially expressed in the mouse embryo during establishment
of the first two extraembryonic cell lineages involved in implantation.
Dev. Biol. 166, 259–267.
Paredes, A., Romero, C., Dissen, G.A., DeChiara, T.M., Reichardt, L., Cornea,
A., Ojeda, S.R., Xu, B., 2004. TrkB receptors are required for follicular
growth and oocyte survival in the mammalian ovary. Dev. Biol. 267,
430–449.Paria, B.C., Dey, S.K., 1990. Preimplantation embryo development in vitro:
cooperative interactions among embryos and role of growth factors. Proc.
Natl. Acad. Sci. U. S. A. 87, 4756–4760.
Pyle, A.D., Lock, L.F., Donovan, P.J., 2006. Neurotrophins mediate human
embryonic stem cell survival. Nat. Biotechnol. 24, 344–350.
Raap, U., Goltz, C., Deneka, N., Bruder, M., Renz, H., Kapp, A., Wedi, B.,
2005. Brain-derived neurotrophic factor is increased in atopic dermatitis and
modulates eosinophil functions compared with that seen in nonatopic
subjects. J. Allergy Clin. Immunol. 115, 1268–1275.
Robert, C., McGraw, S., Massicotte, L., Pravetoni, M., Gandolfi, F., Sirard,
M.A., 2002. Quantification of housekeeping transcript levels during the
development of bovine preimplantation embryos. Biol. Reprod. 67,
1465–1472.
Robertson, S.A., Sjoblom, C., Jasper, M.J., Norman, R.J., Seamark, R.F., 2001.
Granulocyte-macrophage colony-stimulating factor promotes glucose trans-
port and blastomere viability in murine preimplantation embryos. Biol.
Reprod. 64, 1206–1215.
Ross, A.H., McKinnon, C.A., Daou, M.C., Ratliff, K., Wolf, D.E., 1995.
Differential biological effects of K252 kinase inhibitors are related to
membrane solubility but not to permeability. J. Neurochem. 65, 2748–2756.
Seifer, D.B., Feng, B., Shelden, R.M., 2006. Immunocytochemical evidence for
the presence and location of the neurotrophin-Trk receptor family in adult
human preovulatory ovarian follicles. Am. J. Obstet. Gynecol. 194,
1129–1134 (discussion 1134-6).
Spears, N., Molinek, M.D., Robinson, L.L., Fulton, N., Cameron, H., Shimoda,
K., Telfer, E.E., Anderson, R.A., Price, D.J., 2003. The role of neurotrophin
receptors in female germ-cell survival in mouse and human. Development
130, 5481–5491.
Tapley, P., Lamballe, F., Barbacid, M., 1992. K252a is a selective inhibitor of the
tyrosine protein kinase activity of the trk family of oncogenes and
neurotrophin receptors. Oncogene 7, 371–381.
Wang, Y.,Wang, F., Sun, T., Trostinskaia, A.,Wygle, D., Puscheck, E., Rappolee,
D.A., 2004. Entire mitogen activated protein kinase (MAPK) pathway is
present in preimplantation mouse embryos. Dev. Dyn. 231, 72–87.
Yuan, J., Yankner, B.A., 2000. Apoptosis in the nervous system. Nature 407,
802–809.
